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).a b s t r a c t
Trisomy 21 (T21) is the most common chromosome abnormality in humans and is associated with a
spectrum of phenotypes, including cognitive impairment, congenital heart defects and immune system
defects. In addition, T21 is also associated with abnormalities of fetal membranes including cho-
rioamniotic separation, delayed fusion of the chorioamniotic membranes, defects in syncytiotrophoblast
formation, as well as amniocyte senescence. There is evidence indicating miRNAs encoded by sequences
on chromosome 21 (Chr-21) are involved in several of the cognitive and neurological phenotypes of T21,
but the role of Chr-21 derived miRNAs in fetal membrane abnormalities associated with T21 has not been
investigated. In the current study, we determined the expression patterns of three miRNAs derived from
a cluster on Chr-21 e hsa-miR-99a, hsa-miR-125b and hsa-let-7c in chorioamniotic membranes obtained
from term pregnancies with spontaneous rupture (n ¼ 20). Tissue and location speciﬁc expression
patterns within the chorioamniotic membranes were identiﬁed. The rupture zone in the choriodecidua
had distinct expression patterns compared to other fetal membrane locations. Despite the increased gene
dosage associated with T21, the expression of all three miRNAs was reduced in cultured T21 amniocytes
as compared to cultured euploid amniocytes. In silico analysis of experimentally validated targets of the
three miRNAs suggest these Chr-21 derived miRNAs play a potential role in fetal membrane rupture and
the fetal membrane defects associated with T21.
© 2016 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Trisomy 21 (T21) is associated with abnormalities of the fetal
membranes, including chorioamniotic separation and delayed
fusion of the amnion and chorion [1e3]. Cytotrophoblast abnor-
malities and early amniocyte senescence have also been reportedome 21; miRNA, microRNA;
e of the Dean, Suite 4-100,
onya.washington@vcuhealth.
W. Walsh), colleen.jackson-
u.edu (K.J. Archer), jerome.
hio State University, Colum-
r Ltd. This is an open access article[4,5]. Early senescence of fetal extraembryonic tissues has been
proposed to contribute to preterm birth [6]. The underlying path-
ophysiological explanations for these abnormalities has not been
elucidated. Epigenetic alterations in the chorion and amnion (dif-
ferential DNA methylation) have been reported, raising the possi-
bility that both chromosome dose, as well as epigenetic factors,
contribute to dysfunction associated with cells in the fetal mem-
branes [7].
MicroRNAs (miRNAs) are small (20e24 nucleotides) single-
stranded, noncoding, regulatory RNA molecules. They are
involved in post-transcriptional regulation of gene expression
either by complimentary binding to the 30 untranslated region of
their target mRNA, thereby inhibiting translation or inducing
mRNA degradation [8,9]. Altered expression of microRNAs,
including those encoded on chromosome 21 (Chr-21), are thought
to contribute to the phenotypes associated with T21 [10,11]. How-
ever, the role of these miRNAs in the fetal membrane abnormalitiesunder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/
Fig. 1. Sites of tissue collection. The image of the placenta with the fetal membranes
showing the representative sites of tissue collection by region i.e. gross sites for the
membrane rupture called the Rupture Zone (RZ), Mid-Region (MR) and the Peri-
placental (PP) regions. For RZ, MR and PP regions tissues were collected from both
the amnion (A) and the choriodecidua (C) separately.
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the pattern of expression of a cluster of Chr-21 microRNAs that are
potential candidates for altering fetal membrane function in T21.
We determined the relative levels of expression of the 3 microRNAs
in this cluster in the amnion and choriodecidua, as well as differ-
ences in expression in different locations within the fetal mem-
branes. Examination of in vitro cultured amniocytes from normal
pregnancies and pregnancies hosting a T21 fetus revealed that T21
is associated with reduced expression levels of these three micro-
RNAs. Based on the known roles of these microRNAs in the epige-
netic control of gene expression, some of the fetal membrane
structural defects and cellular abnormalities associated with T21
could be explained by altered expression of this microRNA cluster.
2. Methods
2.1. Study population
Self-reported African-American women admitted at MCV Hos-
pitals, Richmond, VA, with spontaneous labor at term (deﬁned as
more than 37 weeks of gestation) with rupture of membranes
(n ¼ 20) were recruited for the study. Women with multiple ges-
tations, fetal anomalies, connective tissue diseases and pregnancy
complications requiring induction of labor were excluded. Fetal
membrane specimens were collected as described below from 12
male and 8 female fetal subjects delivered from 20 term
pregnancies.
In order to test the effect of gene dosage on the expression of the
Chr-21 localized miRNA cluster that was assessed in this study,
cultured amniocyte specimens from local cell repository of cry-
opreserved specimens were evaluated from fetuses (race un-
known) with a T21 complement (n ¼ 7; T21 cases) or a disomic
chromosomal complement (n¼ 6; normal controls). Fetal sex of the
amniocyte cultures were as follows: T21 cases (2 males, 5 females);
normal controls (4 males, 2 females).
The study was approved by the Institutional Review Board of
MCV Hospitals, Richmond, VA., and written informed consent was
obtained from the patients before collection of samples.
2.2. Collection of samples
Human placentas and fetal membranes were obtained at the
time of vaginal delivery or when C-section was performed at term.
Fetal membranes specimens were collected within 1e2 h of de-
livery. After visual identiﬁcation of the rupture zone (Fig. 1) as done
previously by Nhan-Chang et al. [12], the two adherent fetal
membranes (amnion and choriodecidua) were separated/teased
apart from the rupture tear line. A piece of membrane tissue
(~2 cm2) spanning the rupture site was dissected sharply from both
the amnion as well as the choriodecidua, constituting the rupture
zone amnion (RZA) and rupture zone choriodecidua (RZC) samples,
respectively. The two membranes were continuously teased apart
and pieces of both the amnion and choriodecidua were dissected at
the mid region, which was halfway between the rupture site and
the placenta, followed by at the peri-placental region, which is
adjacent to the placenta. This method yielded a set of 6 specimens
from each patient: 1) amnion from the rupture zone (RZA), 2)
choriodecidua from the rupture zone (RZC) (3) amnion from the
mid-region (MRA), 4) choriodecidua from the mid-region (MRC), 5)
amnion from the peri-placental region (PPA), 6) choriodecidua
from the peri-placental region (PPC).
The amniocytes from T21 cases and normal controls (deﬁned
above) were established in culture (monolayer cultures in ﬂasks),
propagated in vitro (1e3 passages), and cryopreserved using stan-
dard techniques [13,14]. The frozen cell aliquots were retrieved andmaintained on ice prior to RNA isolation, which was accomplished
as described below. The amniocyte cultures constitute a mixed
population of ﬁbroblast cells, amniotic ﬂuid cells (derived from
fetal membranes and trophoblasts) and epithelial cells (derived
from epithelial fetal skin, bladder and other epithelia). The tissue
culture procedure selects for growth of ﬁbroblast-like cells, fol-
lowed by amniotic ﬂuid cells and epithelial cells with decreasing
proliferative capacity in culture respectively [14].2.3. RNA isolation and miRNA qPCR
For the miRNA-qPCR assays, total RNA was extracted using
miRVana miRNA isolation kit (Ambion Life Technologies) following
the manufacturer's protocol. MicroRNA qPCRs were performed
using the TaqMan MicroRNA Assays (Life Technologies) following
the manufacturer's instructions. Brieﬂy, 10 ng RNA was reverse
transcribed using the target (miRNA) speciﬁc stem-loop RT primer
and the TaqMan MicroRNA reverse transcription kit. The cDNAwas
then ampliﬁed by real-time qRT-PCR using target speciﬁc TaqMan
primer-probe mix. The qRT-PCR was performed in triplicates per
sample (means were used for statistical analysis) and normaliza-
tion was done using small RNA RNU48.2.4. Statistical analysis
For miRNA qPCR assays in amniocyte samples from T21 cases
and controls, normalized qPCR expression values for the three
miRNAs (hsa-miR-99a, hsa-miR-125b and hsa-let-7c) were log2
transformed and used for student's t-test for determining statistical
signiﬁcance (p < 0.05).
Fig. 2. MiRNA expression in amniocytes. Signiﬁcant differences (p < 0.001) in miRNA expression were observed between T21 case (n ¼ 7) and disomic control (n ¼ 6) amniocyte
samples for hsa-miR-let7c (a), hsa-miR-125b (b) and hsa-miR-99a (c).
B.P. Modi et al. / Placenta 49 (2017) 1e9 3For miRNA expression analysis in the fetal membranes
normalized expression values from qPCR for the three miRNAs
(hsa-miR-99a, hsa-miR-125b and hsa-let-7c) from the 6 specimens
collected for each of the 20 participating subjects were log2
transformed prior to statistical analysis. For each miRNA, a random
coefﬁcient mixed effects model predicting log2 expression was ﬁt,
including the location/tissue factor variable as a ﬁxed effect and
subject as a random effect [15]. Linear contrasts from the mixed
effects model were constructed to test the following: MRA versus
MRC; PPA versus PPC; RZA versus RZC; MRA versus PPA; MRA
versus RZA; PPA versus RZA; MRC versus PPC; MRC versus RZC; PPCversus RZC; and Amnion versus Choriodecidua. Adjusted p-values
are reported for the linear contrasts using the single-step method
(p < 0.05 was considered signiﬁcant) [16].
To compare male and female fetal subjects with respect to
miRNA log2 qPCR expression,Welch's t-test was performed for each
miRNA (let-7c, miR-125b and miR-99a), location (MR, PP, RZ and
VP) and tissue (Amnion, Choriodecidua), adjusting for possible
unequal variances between the groups. A Bonferroni correctionwas
used to control for multiple comparisons and an adjusted alpha
level of 0.0071 or below was considered signiﬁcant [16].
All statistical analyses were performed in the R programming
Fig. 3. MiRNA expression in fetal membranes. qPCR results for log2 expression of hsa-let-7c (a), hsa-miR-125b (b) and hsa-miR-99a (c) for each group/site of collection are shown.
(PP¼Periplacental, MR ¼ MidRegion, RZ ¼ Rupture Zone; A ¼ Amnion/C ¼ Choriodecidua). (Sample N ¼ 20). Data are represented as Mean ± Standard Error.
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The miRNA target prediction ﬁlter in Qiagen's Ingenuity®
Pathway Analysis tool (IPA®, QIAGEN Redwood City, www.qiagen.
com/ingenuity) was used to identify potential target genes for
hsa-miR-125b, hsa-miR-99a and hsa-let-7c. Pathway analysis was
performed in IPA on target genes with experimentally observed
interactions with the miRNAs.3. Results
3.1. Trisomy impacts expression of the Chr21Orf34 microRNA
cluster
The qPCR miRNA expression assays that were completed on
cultured amniocytes revealed signiﬁcant differences (p < 0.05) in
the expression of all three miRNAs between the T21 cases (n ¼ 7)
Table 1
Pairwise comparisons of miRNA expression by tissue and location. The differences (log2
efﬁcient mixed effects model for all pairwise comparisons are shown for hsa-let7c, hsa-
Comparison Let-7c Estimate (Adjusted p-value)
MRA vs. MRC 0.8127 (<0.001)
PPA vs. PPC 0.8161 (0.0873)
RZA vs. RZC 1.6851 (<0.001)
A vs. C 1.1046 (<0.001)
MRA vs. PPA 0.1980 (0.961)
MRA vs. RZA 0.2743 (0.287)
PPA vs. RZA 0.4722 (0.648)
MRC vs. PPC 0.1945 (0.638)
MRC vs. RZC 1.1466 (<0.001)
PPC vs. RZC 1.3412 (<0.001)compared to disomic controls (n ¼ 6), with reduced expression
levels in T21 amniocytes. For each miRNA, dot-plots of log2
expression (normalized by RNU48) by case and control are pre-
sented in Fig. 2.3.2. Differential miRNA expression patterns are observed between
the amnion and the choriodecidua and at different locations within
the choriodecidua
For each miRNA, normalized qPCR expression values for all
samples (n ¼ 20) were log2 expression transformed for each of the
location/tissue types and used for statistical analysis. qPCR results
are shown in Fig. 3. The differences and adjusted p-values for linear
contrasts from the random coefﬁcient mixed effects model for all
pairwise comparisons are reported in Table 1 and visually displayed
in Fig. 4. Comparisons between the amnion and the choriodecidua
at different locations revealed that all three miRNAs had signiﬁcant
expression differences at the rupture zone. For the non-rupture
sites, for miR99a and let-7c there were signiﬁcant expressioncontrast estimates) and adjusted p-values for linear contrasts from the random co-
miR-125b and hsa-miR-99a. (p < 0.05, considered signiﬁcant, shown in bold).
miR-125b Estimate (Adjusted p-value) miR-99a Estimate
(Adjusted p-value)
0.5421 (0.1222) 1.3674 (<0.001)
1.0005 (0.0331) 1.3056 (<0.001)
1.0628 (<0.001) 1.5455 (<0.001)
0.8685 (<0.001) 1.4062 (<0.001)
0.70407 (0.0643) 0.1492 (0.9879)
0.01895 (1.0000) 0.2807 (0.2066)
0.72302 (0.3538) 0.4299 (0.5728)
0.24567 (0.3453) 0.2110 (0.4481)
0.53970 (0.0757) 0.4588 (0.0027)
0.78537 (0.0024) 0.6698 (<0.001)
Fig. 4. Comparison of miRNA expression by tissue and location. Dot-plot of log2 expression for hsa-let7c (a), hsa-miR-125b (b) and hsa-miR-99a (c) are shown for each specimen
collection location, separated by amnion (left) versus choriodecidua (right). Each subject's observations are connected with a line.
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were differentially expressed between the amnion and the cho-
riodecidua at the peri-placental region. None of the three miRNAs
had signiﬁcant differences at any location within the amnion.
Comparatively, the choriodecidua showed signiﬁcant differences
(lower abundance) between the rupture zone and non-rupture
sites, with all three miRNAs showing signiﬁcant lower abun-
dances between the rupture zone and the peri-placental region,
and miR-99a and let-7c showing signiﬁcant differences (lower
abundance) between the rupture zone and the mid-region cho-
riodecidua as well.3.3. MiRNA correlation in amnion and the choriodecidua by
location
Pearson's correlationwas used to examine the strength of linear
relationship (pairwise) between the log2 expression of the three
miRNAs by location for amnion (Table 2) and for the choriodecidua
(Table 3). All pairwise miRNA relationships in all 3 locations in the
amnion as well as the choriodecidua were positively correlated,
though the strength of correlation (determined by r) varied with
specimen tissue/site. For the periplacental region, all pairwise
miRNA comparisons showed signiﬁcant correlations (p < 0.05) for
Table 2
Pairwise Pearson's correlation for log2 miRNA expression by location for amnion. The strength of linear relationship (pairwise) between the log2 expression of the three
miRNAs in the amnion by location is shown. Values represent Pearson's coefﬁcient of correlation (r) with estimated p-values in parentheses. (p < 0.05 considered signiﬁcant,
shown in bold).
Comparison Periplacental r (p-value) MidRegion r (p-value) Rupture Zone r (p-value)
let-7c & miR-99a 0.627 (0.003) 0.255 (0.28) 0.407 (0.07)
let-7c & miR-125b 0.560 (0.01) 0.209 (0.38) 0.029 (0.90)
miR-99a & miR-125b 0.541 (0.01) 0.291 (0.21) 0.336 (0.15)
Table 3
Pairwise Pearson's correlation for log2 miRNA expression by location for the choriodecidua. The strength of linear relationship (pairwise) between the log2 expression of
the three miRNAs in the choriodecidua by location is shown. Values represent Pearson's coefﬁcient of correlation (r) with estimated p-values in parentheses. (p < 0.05
considered signiﬁcant, shown in bold).
Comparison Periplacental r (p-value) MidRegion r (p-value) Rupture Zone r (p-value)
let-7c & miR-99a 0.469 (0.04) 0.445 (0.05) 0.383 (0.10)
let-7c & miR-125b 0.514 (0.02) 0.495 (0.03) 0.453 (0.04)
miR-99a & miR-125b 0.665 (0.001) 0.362 (0.12) 0.646 (0.002)
Table 4
Ingenuity pathway analysis of the genes targeted by hsa-miR-99a, hsa-miR-125b
and hsa-let-7c. Key ﬁndings from the pathway analysis (performed in IPA) of the
212 genes (Table S1) targeted by the three miRNAs in the Chr21 cluster are
described. The Top Canonical Pathways (4A), Top Diseases and Disorders (4B), Top
Molecular and Cellular Functions (4C) and Physiological System Development and
Functions (4D) over-represented in the target genes are shown.
4A: Top canonical pathways
Name p-value Overlap
Bladder Cancer Signaling 1.04E-09 12.60%
Chronic Myeloid Leukemia Signaling 5.26E-10 11.50%
Glioblastoma Multiforme signaling 4.18E-13 10.70%
Colorectal Cancer Metastasis Signaling 3.80E-09 6.50%
Molecular Mechanisms of Cancer 3.61E-12 6.10%
4B: Top diseases and disorders
Name p-value No. of genes
Organismal Injury and Abnormalities 3.7E-07 - 3.82E-18 153
Cancer 3.7E-07 - 3.82E-18 151
Reproductive System Disease 3.7E-07 - 5.73E-15 101
Tumor Morphology 2.02E-07 - 3.85E-17 51
Developmental Disorder 3.68E-07 - 2.88E-14 45
4C: Top molecular and cellular functions
Name p-value No. of genes
Cellular Growth and Proliferation 3.70E-07 - 1.34E-20 125
Cellular Development 3.70E-07 - 1.34E-20 112
Cell Death and Survival 3.32E-07 - 5.40E-18 110
Cellular Movement 3.10E-07 - 3.43E-13 70
Cell Cycle 3.70E-07 - 2.93E-16 64
4D: Physiological system development and function
Name p-value No. of
genes
Organismal Development 3.31E-07 - 1.03E-
17
115
Organismal Survival 5.59E-15 - 3.97E-
18
90
Tissue Morphology 1.22E-07 - 4.65E-
14
78
Hematological System Development and
Function
3.21E-07 - 6.85E-
14
67
Lymphoid Tissue Structure and Development 3.21E-07 - 2.97E-
14
62
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correlations in expression between miRNAs were observed in the
choriodecidua at the mid-region (let-7c and miR-125b) and at the
rupture zone (let-7c and miR-125b, as well as miR-99a and miR-
125b) with miR-99a and miR-125b showing a strong correlation
(r > 0.5) at this site.
3.4. Pathway analysis of genes targeted by miRNAs
MicroRNA target prediction ﬁlter in IPA identiﬁed a total of 217
experimentally observed miRNA-target gene interactions (Supple-
mentary Information, Table S4). The 212 target genes from these
interactions were used for core pathway analysis in IPA to identify
pathways, diseases & bio-functions and networks that are “over-
represented” in target genes of the Chr-21 microRNA cluster. The
key ﬁndings from the pathway analysis are shown in Table 4. Of
note, several of the functional annotations suggest involvement of
cell survival, cell death and cellular development pathways (mo-
lecular mechanisms of cancer) which play a role in fetal membrane
rupture. In addition, a signiﬁcant number of targeted genes overlap
with the categories of reproductive system disease (101 genes) and
developmental disorder (45 genes), which also have a strong as-
sociation with preterm birth, as well as T21. The top network
(Fig. 5), based on the functional annotations of the target genes, had
26 focus molecules (26 of the 212 target genes) with associated
network functions involving the cell cycle, connective tissue
development and function, and cancer. All of these functions have
been shown to have strong correlations with membrane rupture
and/or phenotypic traits associated with Down's syndrome.
3.5. Fetal gender and miRNA expression
Fetal gender is known to be associated with adverse pregnancy
outcomes [18,19]. Male (n ¼ 12) and female (n ¼ 8) fetal subjects in
the study were compared with respect to miRNA expression (log2
qPCR estimates) for each miRNA for each of the 6 groups or sam-
pling sites. Only let-7c in mid-region choriodecidua samples was
signiﬁcantly different (p < 0.0071) when comparing fetal gender
(Supplemetary Information, Tables S1-S3).
4. Discussion
Increasing numbers of investigators are identifying miRNAs to
be involved in pathologies of several diseases and disorders,
including the features of T21 [10,11,20,21]. Expression patterns ofmiRNAs have been studied in the placenta as well as the cho-
rioamniotic membranes and associations with human pregnancy,
gestational age, and parturition and pregnancy complications (such
as preeclampsia and preterm labor) have been found [22e25].
Fig. 5. The top IPA network (Score¼ 48) with 26 of the 212 experimentally observed target genes of the 3 miRNAs. The associated network functions are cell cycle, connective tissue
development and function and cancer.
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expression and homeostasis, which is perturbed in preterm pre-
mature rupture of membranes (PPROM). Interestingly, the rela-
tionship between miRNAs and ECM is thought to be bi-directional
with studies suggesting that not only can miRNAs regulate ECM
composition, but the ECM can also affect miRNA expression and
function [26].
Despite the presence of three chromosomes 21 (a trisomic
imbalance), the T21 amniocyte specimens showed reduced
expression of the microRNA cluster. This has been observed by
others who quantitated expression of the same microRNAs in other
tissue types and found reduced expression in T21 [11,20]. However,
other studies have documented increased expression of thesemiRNAs in T21 as compared to euploid controls [10,21,27]. These
apparent discrepancies could be attributed to differences in the
tissue specimens investigated or differences in normalization
techniques. Reduced expression of the microRNAs in the face of
increased gene dosage may reﬂect epigenetic changes such as DNA
methylation that dampen expression [28]. The reduced expression
of the three microRNAs would presumably increase the expression
of the proteins encoded by the target mRNAs. Although all three
miRNAs are known to be expressed in the placenta and cho-
rioamniotic membranes, an in-depth expression analysis has not
been performed. Prior studies investigating the roles of these
miRNAs the in context of other diseases reveal ﬁndings suggesting a
true potential for their involvement in fetal membrane pathology.
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cers and plays crucial roles in the PI3K/AKT and NF-kB signaling
pathways [29,30]. Infact, the miR-99a/let-7c/miR-125b locus on
Chr-21 is phylogenetically conserved and was shown to be tran-
scribed as a polycistronic message and regulates TGFb/Wnt
signaling pathways in hematopoietic stem and progenitor cell ho-
meostasis [31]. Members of the miR-125 family of miRNAs are
involved in diverse cell functions and have been associated with
several diseases. MiR-125miRNAs target a range of genes, including
transcription factors and matrix metalloproteinases (MMPs) which
are involved in ECMmetabolism and also have important functions
in immunological pathways. Another study found that miR-125b
was upregulated in third trimester placentas compared to ﬁrst
trimester placentas, suggesting it has a role in gestational age
[22,32]. Let-7 miRNAs are negatively regulated by the RNA-binding
protein, Lin28, and both act downstream of the NF-kB signaling
pathways. Like miR-125b, let-7 miRNAs, including let-7c were
upregulated in third trimester human placentas compared to the
ﬁrst trimester [22]. In support of our results, another study found
tissue-speciﬁc let-7c expression differences at term, with signiﬁ-
cantly reduced expression in choriodecidua as compared to amnion
and placenta [33].
In the current study, in addition to the tissue-speciﬁc expression
patterns, we also show differential expression patterns at different
locations within the choriodecidua. Differences between the
rupture zone and the non-rupture sites are especially biologically
relevant. The rupture site of fetal membranes is characterized by
unique histologic and biochemical changes. These changes are
observed even in the portion of fetal membranes overlying the
cervix (thought to be eventual site of spontaneous rupture) in pa-
tients at term without labor. This area is termed as the “zone of
altered morphology” (ZAM) and is characterized by increased
thickness of connective tissue and decreased thickness of cyto-
trophoblast and decidua [34e37]. These changes would require
large-scale transcriptional reprogramming, which can be carried
out, at least in part, by miRNA-regulation. Nhan-Chang et al. [12]
showed gene expression differences between the amnion and the
choriodecidua at both the rupture as well as non-rupture sites,
whereas within each fetal membrane individually, only the cho-
riodecidua showed gene expression differences between the
rupture and non-rupture sites. These results are in accordance with
the miRNA expression patterns in our study, and support the
concept that the altered gene expression in fetal membranes in the
rupture zone could be due to altered miRNA expression patterns. It
is important to note that the decreased thickness in the cyto-
trophoblast and maternal decidual cell layers at the rupture site in
the chorion as compared to non-rupture sites [34e37] can inﬂu-
ence the observed miRNA expression levels at these sites.
Furthermore, the genes identiﬁed by Nhang-Chang et al. (such as
IL-6, IL1RN, CXCL12, ADAMTS5) were involved in inﬂammatory
response, immunetolerance pathways as well as ECM-receptor in-
teractions. This suggests that miRNAs from the Chr21orf34 locus
could be involved in regulation of these pathways in the fetal
membranes as well, which is quite plausible considering the evi-
dence for these functional roles is already established in other
tissues and disease states [26,29e32]. In silico pathway analysis of
the experimentally observed gene targets of the three miRNAs
revealed an over-representation of genes related to cellular growth
and proliferation, cell death and cell survival pathways, all of which
are crucial in ECM function duringmembrane rupture [38]. Notably,
the top network based on functional annotation of the genes tar-
geted by the three miRNAs included COL1A2, which is one of the
major ﬁbrillar collagens present in fetal membranes contributing to
the tensile strength of the amnion and associated with preterm
birth [39]. The network also included SMAD which suggestsinvolvement of the TGFb-Smad signaling pathway which plays a
role in ECM metabolism and fetal membrane rupture via tran-
scription regulation of various collagens, MMPs and tissue in-
hibitors of metalloproteinases (TIMPs) [40,41].
In conclusion, we show evidence for distinct tissue and region
speciﬁc miRNA expression patterns in fetal membranes from sub-
jects with spontaneous term labor. These miRNAs are expressed at
a reduced level in T21 and this alteration may promote abnormal-
ities in fetal membranes associated with T21, including chorio-
amnion separation or delayed fusion of the chorion and amnion.
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